Zomedica Corp. (ZOMDF)
0.0789
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Zomedica Shareholders Equity (Quarterly) : 107.28M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 107.28M |
| March 31, 2026 | 110.94M |
| December 31, 2025 | 115.40M |
| September 30, 2025 | 119.69M |
| June 30, 2025 | 125.36M |
| March 31, 2025 | 132.44M |
| December 31, 2024 | 195.66M |
| September 30, 2024 | 202.84M |
| June 30, 2024 | 208.72M |
| March 31, 2024 | 231.90M |
| December 31, 2023 | 240.02M |
| September 30, 2023 | 260.88M |
| June 30, 2023 | 259.48M |
| March 31, 2023 | 263.06M |
| December 31, 2022 | 267.39M |
| September 30, 2022 | 268.78M |
| June 30, 2022 | 266.22M |
| March 31, 2022 | 269.04M |
| December 31, 2021 | 270.89M |
| September 30, 2021 | 271.56M |
| June 30, 2021 | 276.07M |
| March 31, 2021 | 277.53M |
| December 31, 2020 | 63.03M |
| September 30, 2020 | 53.38M |
| June 30, 2020 | 29.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.952M |
| December 31, 2019 | 2.096M |
| September 30, 2019 | 5.034M |
| June 30, 2019 | 7.683M |
| March 31, 2019 | -1.880M |
| December 31, 2018 | 3.657M |
| September 30, 2018 | 2.910M |
| June 30, 2018 | 4.734M |
| March 31, 2018 | 3.629M |
| December 31, 2017 | |
| September 30, 2017 | 6.132M |
| June 30, 2017 | 4.175M |
| March 31, 2017 | 2.766M |
| December 31, 2016 | 4.134M |
| September 30, 2016 | 4.936M |
| June 30, 2016 | 2.098M |
| March 31, 2016 | 2.929M |
| February 29, 2016 | |
| November 30, 2015 | |
| August 31, 2015 | |
| May 31, 2015 | |
| February 28, 2015 | 0.1414M |
| November 30, 2014 | 0.1745M |
| August 31, 2014 | 0.1927M |
| May 31, 2014 | 0.2036M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biomerica, Inc. | 2.63M |
| Univec, Inc. | -18.31M |
| Lantheus Holdings, Inc. | 1.312B |
| IDEXX Laboratories, Inc. | 1.613B |
| Neogen Corp. | 2.093B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 118.15M |
| Total Liabilities (Quarterly) | 10.86M |
| Debt to Equity Ratio | 0.0171 |
| Current Ratio | 6.431 |
| Net Debt Paydown Yield | 0.17% |